The new top 20 pharma list: Takeda jumps on, Biogen pushed out — and more big changes are on the way
Takeda CEO Christophe Weber is getting the Big Pharma status he wanted with his $62 billion Shire buyout. The pharma company, with a big R&D hub in Boston/Cambridge, has leapt on to the top 20 list of the world’s largest pharma caps, as ranked by GlobalData using end-of-Q1 market caps.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 63,000+ biopharma pros reading Endpoints daily — and it's free.